Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey I Zwicker

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2024
Trousseau syndrome: management of refractory VTEJeffrey I Zwicker
Thrombosis Research|May 4, 2010
Predictive value of tissue factor bearing microparticles in cancer associated thrombosisJeffrey I Zwicker
Seminars in Thrombosis and Hemostasis|November 5, 2010
Impedance-based flow cytometry for the measurement of microparticlesJeffrey I Zwicker
Seminars in Thrombosis and Hemostasis|July 23, 2008
Tissue factor-bearing microparticles and cancerJeffrey I Zwicker
Blood|September 15, 2022
Tranexamic acid as a stopgap for low platelets?Jeffrey I Zwicker
Blood|April 1, 2017
Risking thromboembolism: podoplanin and gliomaJeffrey I Zwicker
Thrombosis Research|May 28, 2014
Unconventional approaches to the prevention of cancer associated thrombosisJeffrey I Zwicker
Thrombosis Research|June 30, 2022
The impact of warfarin on overall survival in cancer patientsThita Chiasakul, Jeffrey I Zwicker
Cancer Treatment and Research|July 19, 2019
Anticoagulation in the Setting of Primary and Metastatic Brain TumorsCharlene Mantia, Jeffrey I Zwicker
Thrombosis Research|August 2, 2020
Inpatient prophylaxis in cancer patients: where is the evidence?Rushad Patell, Jeffrey I Zwicker
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Hematology. American Society of Hematology. Education Program|December 7, 2024
Trousseau syndrome: management of refractory VTEJeffrey I Zwicker
Thrombosis Research|May 4, 2010
Predictive value of tissue factor bearing microparticles in cancer associated thrombosisJeffrey I Zwicker
Seminars in Thrombosis and Hemostasis|November 5, 2010
Impedance-based flow cytometry for the measurement of microparticlesJeffrey I Zwicker
Seminars in Thrombosis and Hemostasis|July 23, 2008
Tissue factor-bearing microparticles and cancerJeffrey I Zwicker
Blood|September 15, 2022
Tranexamic acid as a stopgap for low platelets?Jeffrey I Zwicker
Blood|April 1, 2017
Risking thromboembolism: podoplanin and gliomaJeffrey I Zwicker
Thrombosis Research|May 28, 2014
Unconventional approaches to the prevention of cancer associated thrombosisJeffrey I Zwicker
Thrombosis Research|June 30, 2022
The impact of warfarin on overall survival in cancer patientsThita Chiasakul, Jeffrey I Zwicker
Cancer Treatment and Research|July 19, 2019
Anticoagulation in the Setting of Primary and Metastatic Brain TumorsCharlene Mantia, Jeffrey I Zwicker
Thrombosis Research|August 2, 2020
Inpatient prophylaxis in cancer patients: where is the evidence?Rushad Patell, Jeffrey I Zwicker
Pageof 11